Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) EV to EBIT (2024 - 2026)

Updated

Alnylam Pharmaceuticals' (ALNY) EV to EBIT came in at 36.96 for Q2 2026, down 32.4% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) EV to EBIT (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to EBIT at Alnylam Pharmaceuticals was 28.31; for FY2025, it was 99.15.

  • According to Business Quant data, EV to EBIT for the three prior quarters was 54.70 (Q1 2026), 99.15 (Q4 2025) and 216.74 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.96
Mar 31, 2026 54.70
Dec 31, 2025 99.15
Sep 30, 2025 216.74
Jun 30, 2024 277.61
API Access

Alnylam Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ALNY&period=max&api_key=YOUR_API_KEY